Related Experiment Video
Updated: May 12, 2026
09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
Expression of angiopoietin-TIE system components in angiosarcoma
Darya Buehler1, Patrick Rush, Jason R Hasenstein
1Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Summary
This study investigated the angiopoietin-tunica interna endothelial cell kinase (ANGPT-TIE) system in angiosarcoma. Increased expression of ANGPT-TIE proteins correlates with better prognosis and less aggressive tumors.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Angiosarcoma is an aggressive cancer originating from endothelial cells.
- The role of the angiopoietin-tunica interna endothelial cell kinase (ANGPT-TIE) system in angiosarcoma is not well understood.
- This system plays a crucial role in blood vessel formation and maintenance.
Purpose of the Study:
- To investigate the expression and prognostic significance of angiopoietin-1, angiopoietin-2, TIE1, and TEK (TIE2) proteins in angiosarcoma.
- To explore correlations between protein expression and patient survival and pathological features.
Main Methods:
- Immunohistochemical evaluation of angiosarcoma tissue samples from 51 patients.
- Correlation analysis of protein expression levels with overall survival and clinicopathological characteristics.
Main Results:
- Moderate to strong expression of angiopoietin-1, TIE1, and TEK (TIE2) was common in angiosarcomas.
- Increased angiopoietin-1 expression was linked to improved patient survival.
- Higher expression of angiopoietin-2, TIE1, and TEK (TIE2) correlated with vasoformative architecture.
Conclusions:
- Components of the ANGPT-TIE system are frequently expressed in angiosarcomas.
- Reduced expression of these proteins indicates non-vasoformative, more aggressive tumors.
- The ANGPT-TIE system may serve as a potential therapeutic target or prognostic marker in angiosarcoma.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...